Large Cell Neuroendocrine Carcinoma of the Lung
12 clinical trials · Condition
◉ Watch Large Cell Neuroendocrine Carcinoma of the Lung
| Record | Firm | Date |
|---|---|---|
| A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung (NCT05470595) | Technische Universität Dresden | 2022-01-18 |
| Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC (NCT04010357) | Case Comprehensive Cancer Center | 2020-01-13 |
| Pembrolizumab With Chemotherapy in Metastatic or Unresectable High Grade Gastroenteropancreatic or Lung Neuroendocrine Carcinoma (NCT03901378) | Ochsner Health System | 2019-10-02 |
| uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung (NCT02755675) | Rigshospitalet, Denmark | 2016-04-01 |
Track Large Cell Neuroendocrine Carcinoma of the Lung automatically
Every clearance here is in the API, with alerts when new ones post.